Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The benefit of pancreatic cancer surveillance in carriers of germline BRCA1/2 pathogenic variants.

Cancer - 1 Jan 2024

Laish Ido, Schechter Menachem, Dancour Alain, Lieberman Sari, Levi Zohar, Goldberg Yael, Kedar Inbal, Hasnis Erez, Half Elizabeth, Levi Gili Reznick, Katz Lior, Vainer Elez D, Genzel Dor, Aharoni Maya, Chen-Shtoyerman Rakefet, Abu-Freha Naim, Raitses-Gurevich Maria, Golan Talia, Bernstein-Molho Rinat, Ben Yehoyada Merav, Gluck Nathan, Rosner Guy

Abstract excerpt

BACKGROUND: Surveillance of high-risk individuals for pancreatic ductal adenocarcinoma (PDAC) is recommended. This study aimed to determine the prevalence and outcomes of PDAC and its precursor lesions in BRCA1/2 pathogenic variants (PVs) carriers undergoing pancreatic surveillance. METHODS: A retrospective multicenter cohort study of pancreatic surveillance outcomes in Israeli BRCA1/2 carriers preferably with a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to BRCA1 Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to BRCA2 Protein

Share to Carcinoma, Pancreatic Ductal

Share to Cohort Studies

Share to Genetic Predisposition to Disease

Share to Germ Cells

Share to Pancreatic Neoplasms

Source

Identifiers

PMID: 37861363
DOI: 10.1002/cncr.35052

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The benefit of pancreatic cancer surveillance in carriers of germline BRCA1/2 pathogenic variants.PMID 37861363Read ↗

Hereditary pancreatic cancer: A proposal for surveillance from the Italian Association for the Study of the Pancreas (AISP).Semantic proximity Read ↗

Surveillance Outcome and Genetic Findings in Individuals at High Risk of Pancreatic Cancer.Semantic proximity Read ↗

Treatment opportunities and future perspectives for pancreatic cancer patients with germline BRCA1-2 pathogenic variantsSemantic proximity Read ↗

Overall survival and clinical characteristics of BRCA mutation carriers with stage I/II pancreatic cancerSemantic proximity Read ↗

BRCA-mutant pancreatic ductal adenocarcinoma.Semantic proximity Read ↗

Targeting pancreatic cancer screening by identification of pathogenic variants of BRCA2/ BRCA1 in healthy individuals who have no known family history of pancreatic cancer: The arguments for and against.Semantic proximity Read ↗

The incidence of pancreatic cancer in BRCA1 and BRCA2 mutation carriersSemantic proximity Read ↗

A prospective observational study of pancreatic cancer risk in men and women with pathogenic variants in BRCA1 or BRCA2Semantic proximity Read ↗

BRCA1 and BRCA2 germline mutations are frequently demonstrated in both high-risk pancreatic cancer screening and pancreatic cancer cohorts.Semantic proximity Read ↗

Benefit of Surveillance for Pancreatic Cancer in High-Risk Individuals: Outcome of Long-Term Prospective Follow-Up Studies From Three European Expert Centers.Semantic proximity Read ↗

The role of germline BRCA1 & BRCA2 mutations in familial pancreatic cancer: A systematic review and meta-analysis.Semantic proximity Read ↗

Prevalence of pancreaticobiliary cancers in Irish families with pathogenic BRCA1 and BRCA2 variants.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.